Equities

Progyny Inc

PGNY:NSQ

Progyny Inc

Actions
Health CareHealth Care Providers
  • Price (USD)14.42
  • Today's Change0.44 / 3.15%
  • Shares traded223.77k
  • 1 Year change-56.12%
  • Beta1.3411
Data delayed at least 15 minutes, as of Nov 21 2024 15:46 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

  • Revenue in USD (TTM)1.14bn
  • Net income in USD57.27m
  • Incorporated2008
  • Employees563.00
  • Location
    Progyny Inc1359 BroadwayNEW YORK 10018United StatesUSA
  • Phone+1 (212) 888-3124
  • Fax+1 (302) 636-5454
  • Websitehttps://www.progyny.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
InnovAge Holding Corp786.51m-15.96m636.83m2.35k--2.44284.170.8097-0.1175-0.11755.791.931.47--17.30334,686.00-3.35-3.72-4.76-4.9017.6420.39-2.28-2.79---2.300.2172--11.0110.4147.54---11.39--
Agilon Health Inc5.35bn-306.78m688.07m1.12k--1.20--0.1285-0.7574-0.952113.131.402.45--3.954,792,792.00-14.04---36.97--2.00---5.73------0.0572--80.74---112.01------
QDM International Inc3.93m1.30m790.14m5.00606.26180.97587.92201.150.00450.00450.01350.0150.5994--21.84785,618.0019.86--34.36--61.80--33.13----436.130.2444--461.81--3,411.87------
AMN Healthcare Services, Inc.3.07bn53.04m944.23m3.59k17.871.064.130.30781.391.3980.2523.431.15--4.86855,604.201.999.322.5912.4131.3432.961.736.62--2.000.55940.00-27.7312.15-52.568.2523.70--
Brookdale Senior Living, Inc.3.10bn-209.17m1.04bn25.20k--3.556.870.3356-0.924-0.92413.681.470.5267--61.66122,977.10-3.56-2.20-4.07-2.4825.6821.71-6.75-4.40--0.25340.9361--6.74-7.8220.73---12.60--
Pennant Group Inc652.30m21.15m1.06bn5.79k44.755.5137.841.620.68790.687921.255.591.12--9.10112,640.603.831.814.542.1420.5521.623.421.92--4.240.36760.0015.1413.76101.40-3.1314.07--
OPKO Health Inc711.41m-133.73m1.08bn3.93k--0.7684--1.52-0.1831-0.18310.99832.060.32998.306.35181,019.80-6.20-7.14-6.86-8.1425.1034.42-18.80-13.832.69-5.360.2418---14.01-2.7042.49---10.19--
Aveanna Healthcare Holdings Inc1.98bn-65.85m1.11bn3.50k------0.5621-0.3438-0.343810.26-0.80211.20--7.56566,707.10-3.99---5.21--30.8731.12-3.32-12.71--0.79061.12--6.028.6279.68---20.76--
Pediatrix Medical Group Inc2.01bn-253.84m1.24bn2.90k--1.70--0.62-3.07-3.0724.078.530.9116--7.11692,068.30-11.530.8579-13.800.9945-----12.651.52--4.840.46110.001.152.97-196.55--14.25--
Progyny Inc1.14bn57.27m1.26bn563.0024.102.8420.961.110.58010.580111.574.921.64--4.142,022,611.008.2611.5011.6316.0221.6821.485.036.64----0.000.0038.3459.52104.35--44.47--
US Physical Therapy Inc645.70m14.10m1.42bn3.90k100.582.9429.022.200.93520.935242.9332.020.6332--8.70165,606.303.127.134.3110.6419.4121.964.939.71--45.420.175358.539.345.91-38.011.785.2613.33
Teladoc Health Inc2.59bn-981.73m1.55bn5.60k--1.03--0.5984-5.78-5.7815.338.770.659220.7312.39462,430.30-24.99-33.54-30.10-34.6370.8268.59-37.91-171.391.69--0.5055--8.1344.1698.39--79.43--
Clover Health Investments Corp1.54bn-95.26m1.68bn552.00--4.90--1.09-0.1961-0.18823.160.68391.80--8.382,797,861.00-11.12---26.66-------6.17-----13.530.00---41.50--37.03------
Data as of Nov 21 2024. Currency figures normalised to Progyny Inc's reporting currency: US Dollar USD

Institutional shareholders

42.72%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 202412.14m13.45%
The Vanguard Group, Inc.as of 30 Sep 20248.40m9.30%
T. Rowe Price Investment Management, Inc.as of 30 Sep 20243.43m3.80%
SSgA Funds Management, Inc.as of 30 Sep 20243.11m3.45%
Pacer Advisors, Inc.as of 30 Sep 20242.49m2.76%
Geode Capital Management LLCas of 30 Sep 20241.92m2.13%
Weatherbie Capital LLCas of 30 Sep 20241.87m2.08%
Invenomic Capital Management LPas of 30 Sep 20241.76m1.95%
Morgan Stanley & Co. LLCas of 30 Sep 20241.73m1.92%
Riverbridge Partners LLCas of 30 Sep 20241.70m1.89%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.